A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology

Proteomics

Volumn 15, Issue 8, 2015, Pages 1390-1404

  Porras, Pablo ^a   Duesbury, Margaret ^a   Fabregat, Antonio ^a   Ueffing, Marius ^b,c   Orchard, Sandra ^a   Gloeckner, Christian Johannes ^b,c,d   Hermjakob, Henning ^a  

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^b Helmholtz Zentrum München German Research Center for Environmental Health   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Bioinformatics; Curation; Data visualization; Molecular interaction database; Parkinson's disease; Protein interaction network

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

AFFINITY CHROMATOGRAPHY; BIOINFORMATICS; CELL CYCLE REGULATION; COMPREHENSION; ENZYME SUBSTRATE; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; MAMMAL CELL; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SCORING SYSTEM; SURFACE PLASMON RESONANCE; WORKFLOW; ANIMAL; COMPUTER GRAPHICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROCEDURES; PROTEIN DATABASE; PROTEOMICS; SOFTWARE;

ANIMALS; COMPUTER GRAPHICS; DATABASES, PROTEIN; HUMANS; LEUCINE-RICH REPEAT SERINE-THREONINE PROTEIN KINASE-2; MOLECULAR SEQUENCE ANNOTATION; PARKINSON DISEASE; PROTEIN INTERACTION MAPS; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; SOFTWARE;

EID: 84926431873     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400390     Document Type: Review

References (89)

1. Alberts, B., The cell as a collection of protein machines: preparing the next generation of molecular biologists. Cell 1998, 92, 291-294.
2. Wang, P. I., Marcotte, E. M., It's the machine that matters: Predicting gene function and phenotype from protein networks. J. Proteomics 2010, 73, 2277-2289.
3. Turinsky, A. L., Razick, S., Turner, B., Donaldson, I. M., Wodak, S. J., Interaction databases on the same page. Nat. Biotechnol. 2011, 29, 391-393.
4. Schramm, S.-J., Jayaswal, V., Goel, A., Li, S. S. et al., Molecular interaction networks for the analysis of human disease: utility, limitations, and considerations. Proteomics 2013, 13, 3393-3405.
5. delas Rivas, J., Fontanillo, C., Protein-protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Comput. Biol. 2010, 6, e1000807.
6. Orchard, S., Ammari, M., Aranda, B., Breuza, L. et al., The MIntAct project - IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 2014, 42, D358-D363.
7. Licata, L., Briganti, L., Peluso, D., Perfetto, L. et al., MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 2012, 40, D857-D861.
8. Chautard, E., Fatoux-Ardore, M., Ballut, L., Thierry-Mieg, N., Ricard-Blum, S., MatrixDB, the extracellular matrix interaction database. Nucleic Acids Res. 2011, 39, D235-D240.
9. Salwinski, L., Miller, C. S., Smith, A. J., Pettit, F. K. et al., The Database of Interacting Proteins: 2004 update. Nucleic Acids Res. 2004, 32, D449-D451.
10. Chatr-aryamontri, A., Breitkreutz, B.-J., Heinicke, S., Boucher, L. et al., The BioGRID interaction database: 2013 update. Nucleic Acids Res. 2013, 41, D816-D823.
11. Hernandez-Toro, J., Prieto, C., delas Rivas, J., APID2NET: unified interactome graphic analyzer. Bioinformatics 2007, 23, 2495-2497.
12. Calderone, A., Castagnoli, L., Cesareni, G., mentha: a resource for browsing integrated protein-interaction networks. Nat. Methods 2013, 10, 690-691.
13. Schaefer, M. H., Fontaine, J.-F., Vinayagam, A., Porras, P. et al., HIPPIE: integrating protein interaction networks with experiment based quality scores. PLoS One 2012, 7, e31826.
14. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M. et al., The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39, D561-D568.
15. Chaurasia, G., Iqbal, Y., Hänig, C., Herzel, H. et al., UniHI: an entry gate to the human protein interactome. Nucleic Acids Res. 2007, 35, D590-D594.
16. Hermjakob, H., Montecchi-Palazzi, L., Bader, G., Wojcik, J. et al., The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat. Biotechnol. 2004, 22, 177-183.
17. Orchard, S., Salwinski, L., Kerrien, S., Montecchi-Palazzi, L. et al., The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat. Biotechnol. 2007, 25, 894-898.
18. Orchard, S., Kerrien, S., Abbani, S., Aranda, B. et al., Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. Nat. Methods 2012, 9, 345-350.
19. Aranda, B., Blankenburg, H., Kerrien, S., Brinkman, F. S. L. et al., PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat. Methods 2011, 8, 528-529.
20. Fung, D. C. Y., Li, S. S., Goel, A., Hong, S.-H., Wilkins, M. R., Visualization of the interactome: what are we looking at? Proteomics 2012, 12, 1669-1686.
21. Gehlenborg, N., O'Donoghue, S. I., Baliga, N. S., Goesmann, A. et al., Visualization of omics data for systems biology. Nat. Methods 2010, 7, S56-S68.
22. Fahn, S., Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 2003, 991, 1-14.
23. Gasser, T., Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. 2009, 11, e22.
24. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P. et al., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44, 601-607.
25. Paisan-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P. et al., Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44, 595-600.
26. Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J. et al., The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 2006, 15, 223-232.
27. Lewis, P. A., Greggio, E., Beilina, A., Jain, S. et al., The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 2007, 357, 668-671.
28. West, A. B., Moore, D. J., Biskup, S., Bugayenko, A. et al., Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 2005, 102, 16842-16847.
29. Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G. et al., LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J. 2007, 405, 307-317.
30. Gómez-Suaga, P., Fdez, E., Fernández, B., Martínez-Salvador, M. et al., Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease. Neuropharmacology 2014, 85, 45-56.
31. Belluzzi, E., Greggio, E., Piccoli, G., Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2. Biochem. Soc. Trans. 2012, 40, 1111-1116.
32. Boon, J. Y., Dusonchet, J., Trengrove, C., Wolozin, B., Interaction of LRRK2 with kinase and GTPase signaling cascades. Front. Mol. Neurosci. 2014, 7, 94.
33. Russo, I., Bubacco, L., Greggio, E., LRRK2 and neuroinflammation: partners in crime in Parkinson's disease? J. Neuroinflamm. 2014, 11, 52.
34. Schapansky, J., Nardozzi, J. D., LaVoie, M. J., The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. Neuroscience 2014, doi.org/10.1016/j.neuroscience.2014.09.049.
35. Meixner, A., Boldt, K., vanTroys, M., Askenazi, M. et al., A QUICK screen for Lrrk2 interaction partners - leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics. Mol. Cell. Proteomics 2011, 10, M110 001172.
36. Piccoli, G., Condliffe, S. B., Bauer, M., Giesert, F. et al., LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J. Neurosci. 2011, 31, 2225-2237.
37. Piccoli, G., Onofri, F., Cirnaru, M. D., Kaiser, C. J. et al., Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its c-terminal WD40 domain. Mol. Cell. Biol. 2014, 34, 2147-2161.
38. Beilina, A., Rudenko, I.N., Kaganovich, A., Civiero, L. et al., Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. USA 2014, 111, 2626-2631.
39. Prasad, T. S. K., Goel, R., Kandasamy, K., Keerthikumar, S. et al., Human Protein Reference Database-2009 update. Nucleic Acids Res. 2009, 37, D767-D772.
40. Rolland, T., Taşan, M., Charloteaux, B., Pevzner, S. J. et al., A proteome-scale map of the human interactome network. Cell 2014, 159, 1212-1226.
41. Kerrien, S., Orchard, S., Montecchi-Palazzi, L., Aranda, B. et al., Broadening the horizon - level 2.5 of the HUPO-PSI format for molecular interactions. BMC Biol. 2007, 5, 44.
42. Bader, G. D., Hogue, C. W. V., Analyzing yeast protein-protein interaction data obtained from different sources. Nat. Biotechnol. 2002, 20, 991-997.
43. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
44. Wodak, S. J., Vlasblom, J., Turinsky, A. L., Pu, S., Protein-protein interaction networks: the puzzling riches. Curr. Opin. Struct. Biol. 2013, 23, 941-953.
45. Braun, P., Tasan, M., Dreze, M., Barrios-Rodiles, M. et al., An experimentally derived confidence score for binary protein-protein interactions. Nat. Methods 2008, 6, 91-97.
46. Caufield, J. H., Sakhawalkar, N., Uetz, P., A comparison and optimization of yeast two-hybrid systems. Methods 2012, 58, 317-324.
47. Chen, Y.-C., Rajagopala, S. V., Stellberger, T., Uetz, P., Exhaustive benchmarking of the yeast two-hybrid system. Nat. Methods 2010, 7, 667-668.
48. Varjosalo, M., Sacco, R., Stukalov, A., van Drogen, A. et al., Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat. Methods 2013, 10, 307-314.
49. Jimenez, R. C., Quinn, A. F., Garcia, A., Labarga, A. et al., Dasty2, an Ajax protein DAS client. Bioinformatics 2008, 24, 2119-2121.
50. Patil, A., Nakai, K., Nakamura, H., HitPredict: a database of quality assessed protein-protein interactions in nine species. Nucleic Acids Res. 2011, 39, D744-D749.
51. Kamburov, A., Stelzl, U., Herwig, R., IntScore: a web tool for confidence scoring of biological interactions. Nucleic Acids Res. 2012, 40, W140-W146.
52. Villaveces, J. M., Jiménez, R. C., Porras, P., Del-Toro, N. et al., Merging and scoring molecular interactions utilising existing community standards: tools, use-cases and a case study. Database J. Biol. Databases Curation 2015, 2015.
53. Lewis, P. A., Assaying the kinase activity of LRRK2 in vitro. J. Vis. Exp. 2012, 59, 3495.
54. Guerreiro, P. S., Huang, Y., Gysbers, A., Cheng, D. et al., LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models. J. Mol. Med. (Berl.) 2013, 91, 513-522.
55. Orenstein, S. J., Kuo, S.-H., Tasset, I., Arias, E. et al., Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 2013, 16, 394-406.
56. Reyniers, L., del Giudice, M. G., Civiero, L., Belluzzi, E. et al., Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. J. Neurochem. 2014, 2, 239-250.
57. Martin, I., Kim, J. W., Lee, B. D., Kang, H. C. et al., Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 2014, 157, 472-485.
58. Lobbestael, E., Baekelandt, V., Taymans, J.-M., Phosphorylation of LRRK2: from kinase to substrate. Biochem. Soc. Trans. 2012, 40, 1102-1110.
59. Angeles, D. C., Gan, B.-H., Onstead, L., Zhao, Y. et al., Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum. Mutat. 2011, 32, 1390-1397.
60. Angeles, D. C., Ho, P., Chua, L. L., Wang, C. et al., Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. Hum. Mol. Genet. 2014, 23, 3157-3165.
61. Angeles, D. C., Gan, B.-H., Onstead, L., Zhao, Y. et al., Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum. Mutat. 2011, 32, 1390-1397.
62. Haw, R., Hermjakob, H., D'Eustachio, P., Stein, L., Reactome pathway analysis to enrich biological discovery in proteomics data sets. Proteomics 2011, 11, 3598-3613.
63. Kanehisa, M., Goto, S., KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000, 28, 27-30.
64. Maere, S., Heymans, K., Kuiper, M., BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21, 3448-3449.
65. Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P. et al., ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25, 1091-1093.
66. Zuberi, K., Franz, M., Rodriguez, H., Montojo, J. et al., GeneMANIA prediction server 2013 update. Nucleic Acids Res. 2013, 41, W115-W122.
67. Yun, H. J., Park, J., Ho, D. H., Kim, H. et al., LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. Exp. Mol. Med. 2013, 45, e36.
68. Setty, S. R. G., Tenza, D., Truschel, S. T., Chou, E. et al., BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol. Biol. Cell 2007, 18, 768-780.
69. Granata, A., Watson, R., Collinson, L. M., Schiavo, G., Warner, T. T., The dystonia-associated protein torsinA modulates synaptic vesicle recycling. J. Biol. Chem. 2008, 283, 7568-7579.
70. Matta, S., vanKolen, K., da Cunha, R., van den Bogaart, G. et al., LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis. Neuron 2012, 75, 1008-1021.
71. Migheli, R., Del Giudice, M. G., Spissu, Y., Sanna, G. et al., LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization. PloS One 2013, 8, e77198.
72. Chaudhri, M., Scarabel, M., Aitken, A., Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 2003, 300, 679-685.
73. Yaffe, M. B., How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 2002, 513, 53-57.
74. Muda, K., Bertinetti, D., Gesellchen, F., Hermann, J. S. et al., Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3. Proc. Natl. Acad. Sci. USA 2014, 111, E34-E43.
75. Dzamko, N., Deak, M., Hentati, F., Reith, A. D. et al., Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem. J. 2010, 430, 405-413.
76. Fraser, K. B., Moehle, M. S., Daher, J. P. L., Webber, P. J. et al., LRRK2 secretion in exosomes is regulated by 14-3-3. Hum. Mol. Genet. 2013, 22, 4988-5000.
77. MacLean, M., Picard, D., Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperones 2003, 8, 114-119.
78. Kawakami, F., Shimada, N., Ohta, E., Kagiya, G. et al., Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β. FEBS J. 2014, 281, 3-13.
79. Chan, D., Citro, A., Cordy, J. M., Shen, G. C., Wolozin, B., Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2). J. Biol. Chem. 2011, 286, 16140-16149.
80. Haebig, K., Gloeckner, C. J., Miralles, M. G., Gillardon, F. et al., ARHGEF7 (BETA-PIX) acts as guanine nucleotide exchange factor for leucine-rich repeat kinase 2. PLoS One 2010, 5, e13762.
81. Berwick, D. C., Harvey, K., LRRK2: An éminence grise of Wnt-mediated neurogenesis? Front. Cell. Neurosci. 2013, 7, 82.
82. Dzamko, N., Halliday, G. M., An emerging role for LRRK2 in the immune system. Biochem. Soc. Trans. 2012, 40, 1134-1139.
83. Parisiadou, L., Cai, H., LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun. Integr. Biol. 2010, 3, 396-400.
84. Law, B. M. H., Spain, V. A., Leinster, V. H. L., Chia, R. et al., A direct interaction between leucine-rich repeat kinase 2 and specific tubulin isoforms regulates tubulin acetylation. J. Biol. Chem. 2014, 289, 895-908.
85. Kawakami, F., Yabata, T., Ohta, E., Maekawa, T. et al., LRRK2 phosphorylates tubulin-associated tau but not the free molecule: LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth. PloS One 2012, 7, e30834.
86. Yoshida, H., Goedert, M., Phosphorylation of microtubule-associated protein tau by AMPK-related kinases. J. Neurochem. 2012, 120, 165-176.
87. Bailey, R. M., Covy, J. P., Melrose, H. L., Rousseau, L. et al., LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. Acta Neuropathol. 2013, 126, 809-827.
88. Esteves, A. R., Swerdlow, R. H., Cardoso, S. M., LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Exp. Neurol. 2014, 261, 206-216.
89. Goh, K.-I., Choi, I.-G., Exploring the human diseasome: the human disease network. Brief. Funct. Genomics 2012, 11, 533-542.